Efficacy and Safety of Trametinib in Neurofibromatosis Type 1-Associated Plexiform Neurofibroma and Low-Grade Glioma: A Systematic Review and Meta-Analysis

Trametinib has been used in neurofibromatosis type 1 (NF1) patients, especially those with unresectable nerve tumors, but no systematic review based on the latest studies has been published. We conducted this meta-analysis to evaluate the effectiveness and safety of trametinib in treating NF1-relate...

Повний опис

Бібліографічні деталі

Автори:	Dun Wang, Lingling Ge, Zizhen Guo, Yuehua Li, Beiyao Zhu, Wei Wang, Chengjiang Wei, Qingfeng Li, Zhichao Wang
Формат:	Artigo
Мова:	Inglês
Опубліковано:	MDPI AG 2022-07-01
Серія:	Pharmaceuticals
Предмети:	neurofibromatosis type 1 plexiform neurofibroma low-grade Glioma trametinib systematic review meta-analysis
Онлайн доступ:	https://www.mdpi.com/1424-8247/15/8/956
Теги:	Додати тег Немає тегів, Будьте першим, хто поставить тег для цього запису!